Table of Contents

1 Industry Overview

• 1.1 Cancer mTOR Inhibitors Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Cancer mTOR Inhibitors
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Cancer mTOR Inhibitors Market by Type

• 3.1 By Type
  • 3.1.1 Afinitor/Votubia
  • 3.1.2 Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
  • 3.1.3 Torisel (Temsirolimus)
  • 3.1.4 Evertor andndash
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Cancer mTOR Inhibitors Abraxis BioScience (Company Profile, Sales Data etc.)

• 4.2 Adimab (Company Profile, Sales Data etc.)
• 4.3 Celgene Corporation (Company Profile, Sales Data etc.)
• 4.4 Celator Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.5 Eli Lilly (Company Profile, Sales Data etc.)
• 4.6 Exelixis (Company Profile, Sales Data etc.)
• 4.7 GlaxoSmithKline (Company Profile, Sales Data etc.)
• 4.8 HEC Pharm (Company Profile, Sales Data etc.)
• 4.9 Intellikine (Company Profile, Sales Data etc.)
• 4.10 Novartis (Company Profile, Sales Data etc.)
• 4.11 Oneness Biotech (Company Profile, Sales Data etc.)
• 4.12 PIQUR Therapeutics (Company Profile, Sales Data etc.)
• 4.13 Semafore Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.14 Takeda (Company Profile, Sales Data etc.)
• 4.15 Wyeth (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Breast Cancer
  • 6.1.2 Demand in Hematological Malignancy
  • 6.1.3 Demand in Neuroendocrine Tumors
  • 6.1.4 Demand in Hepatocellular Carcinoma
  • 6.1.5 Demand in Glioblastoma
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Cancer mTOR Inhibitors

Table Application Segment of Cancer mTOR Inhibitors

Table Global Cancer mTOR Inhibitors Market 2013-2024, by Application, in USD Million

Table Major Company List of Afinitor/Votubia

Table Major Company List of Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor

Table Major Company List of Torisel (Temsirolimus)

Table Major Company List of Evertor andndash

Table Global Cancer mTOR Inhibitors Market 2013-2018, by Type, in USD Million

Table Global Cancer mTOR Inhibitors Market 2013-2018, by Type, in Volume

Table Global Cancer mTOR Inhibitors Market Forecast 2019-2024, by Type, in USD Million

Table Global Cancer mTOR Inhibitors Market Forecast 2019-2024, by Type, in Volume

Table Abraxis BioScience Overview List

Table Cancer mTOR Inhibitors Business Operation of Abraxis BioScience (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Adimab Overview List

Table Cancer mTOR Inhibitors Business Operation of Adimab (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celgene Corporation Overview List

Table Cancer mTOR Inhibitors Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Celator Pharmaceuticals Overview List

Table Cancer mTOR Inhibitors Business Operation of Celator Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Cancer mTOR Inhibitors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Exelixis Overview List

Table Cancer mTOR Inhibitors Business Operation of Exelixis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table GlaxoSmithKline Overview List

Table Cancer mTOR Inhibitors Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table HEC Pharm Overview List

Table Cancer mTOR Inhibitors Business Operation of HEC Pharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Intellikine Overview List

Table Cancer mTOR Inhibitors Business Operation of Intellikine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Cancer mTOR Inhibitors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Oneness Biotech Overview List

Table Cancer mTOR Inhibitors Business Operation of Oneness Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table PIQUR Therapeutics Overview List

Table Cancer mTOR Inhibitors Business Operation of PIQUR Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Semafore Pharmaceuticals Overview List

Table Cancer mTOR Inhibitors Business Operation of Semafore Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Takeda Overview List

Table Cancer mTOR Inhibitors Business Operation of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Wyeth Overview List

Table Cancer mTOR Inhibitors Business Operation of Wyeth (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Cancer mTOR Inhibitors Sales Revenue 2013-2018, by Company, in USD Million

Table Global Cancer mTOR Inhibitors Sales Revenue Share, by Company, in USD Million

Table Global Cancer mTOR Inhibitors Sales Volume 2013-2018, by Company, in Volume

Table Global Cancer mTOR Inhibitors Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Cancer mTOR Inhibitors Demand Forecast 2019-2024, by Application, in USD Million

Table Cancer mTOR Inhibitors Demand Forecast 2019-2024, by Application, in Volume

Table Cancer mTOR Inhibitors Production 2013-2018, by Region, in USD Million

Table Cancer mTOR Inhibitors Production 2013-2018, by Region, in Volume

Table Global Cancer mTOR Inhibitors Market 2013-2018, by Region, in USD Million

Table Global Cancer mTOR Inhibitors Market Share 2013-2018, by Region, in USD Million

Table Global Cancer mTOR Inhibitors Market 2013-2018, by Region, in Volume

Table Global Cancer mTOR Inhibitors Market Share 2013-2018, by Region, in Volume

Table North America Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in USD Million

Table North America Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in Volume

Table Europe Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Europe Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in Volume

Table South America Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in USD Million

Table South America Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Cancer mTOR Inhibitors Market Size 2013-2018, by Country, in Volume

Table Cancer mTOR Inhibitors Market Forecast 2019-2024, by Region, in USD Million

Table Cancer mTOR Inhibitors Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Cancer mTOR Inhibitors Market Growth 2013-2018, by Type, in USD Million

Figure Global Cancer mTOR Inhibitors Market Growth 2013-2018, by Type, in Volume

Figure North America Cancer mTOR Inhibitors Market Concentration, in 2018

Figure Europe Cancer mTOR Inhibitors Market Market Concentration, in 2018

Figure Asia-Pacific Cancer mTOR Inhibitors MMarket Concentration, in 2018

Figure South America Cancer mTOR Inhibitors Market Concentration, in 2018

Figure Middle East & Africa Cancer mTOR Inhibitors Market Concentration, in 2018

Figure Cancer mTOR Inhibitors Demand in Breast Cancer, 2013-2018, in USD Million

Figure Cancer mTOR Inhibitors Demand in Breast Cancer, 2013-2018, in Volume

Figure Cancer mTOR Inhibitors Demand in Hematological Malignancy, 2013-2018, in USD Million

Figure Cancer mTOR Inhibitors Demand in Hematological Malignancy, 2013-2018, in Volume

Figure Cancer mTOR Inhibitors Demand in Neuroendocrine Tumors, 2013-2018, in USD Million

Figure Cancer mTOR Inhibitors Demand in Neuroendocrine Tumors, 2013-2018, in Volume

Figure Cancer mTOR Inhibitors Demand in Hepatocellular Carcinoma, 2013-2018, in USD Million

Figure Cancer mTOR Inhibitors Demand in Hepatocellular Carcinoma, 2013-2018, in Volume

Figure Cancer mTOR Inhibitors Demand in Glioblastoma, 2013-2018, in USD Million

Figure Cancer mTOR Inhibitors Demand in Glioblastoma, 2013-2018, in Volume

Figure North America Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure North America Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Europe Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Europe Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in Volume

Figure South America Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure South America Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Cancer mTOR Inhibitors Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Cancer mTOR Inhibitors market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Cancer mTOR Inhibitors by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Afinitor/Votubia
Afinitor Disperz andndash; mTOR inhibitor for Rare Pediatric Brain Tumor
Torisel (Temsirolimus)
Evertor andndash
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Abraxis BioScience
Adimab
Celgene Corporation
Celator Pharmaceuticals
Eli Lilly
Exelixis
GlaxoSmithKline
HEC Pharm
Intellikine
Novartis
Oneness Biotech
PIQUR Therapeutics
Semafore Pharmaceuticals
Takeda
Wyeth
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Breast Cancer
Hematological Malignancy
Neuroendocrine Tumors
Hepatocellular Carcinoma
Glioblastoma
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)